Relationship between chronic obstructive pulmonary disease and levels of vitamin D
Amaç: Vitamin D eksikliği, solunum fonksiyonlarında bozulma ile ilişkili olabilir. Çalışmamızda Kronik Obstruktif Akciğer Hastalığı (KOAH) hastalarında solunum fonksiyonları, hastalığın şiddeti ve alevlenme sıklığı ile serum Vitamin D düzeyi arasındaki ilişkiyi belirlemeyi amaçladık. Yöntemler: Polikliniğimize başvuran 70 KOAH hastası (GOLD Sınıflaması Evre II-IV) çalışmaya alındı. 30 sağlıklı gönüllü kontrol grubunu oluşturdu. Klinik bulgular ve solunum fonksiyon testine göre KOAH tanısı kondu. Serum 25-hidroksi vitamin D (25(OH)D) seviyesi immünofloresan yöntemi ile ölçüldü. 20 ng/mL altındaki değerler eksiklik olarak kabul edildi. Vitamin D düzeyi ile cinsiyet, yaş, Vücut Kitle İndeksi (VKİ), sigara içme durumu, komorbiditeler, alevlenme sıklığı arasındaki ilişki araştırıldı. Bulgular: Hasta grubunun yaş ortalaması 60,7 yıldı. Hastaları GOLD sınıflamasına göre ayırdığımızda %40ı Evre II, %30u Evre III, %30u Evre IV KOAHtı. Hasta ve kontrol grupları arasında serum 25(OH)D düzeyi bakımından anlamlı farklılık görülmedi. Vitamin D düzeyi kontrol grubunda 9,3 ±6,0 ng/mL, Evre II KOAHda 9,7± 8,5 ng/mL, Evre IIIte 9,6 ± 6,2 ng/mL ve Evre IVte 5,1 ±2,4 ng/mL olarak belirlendi. Evre IV te Vitamin D düzeyi düşüklüğü istatistiksel olarak anlamlıydı (p=0.03). Hasta grubunda düşük FEV1, düşük 25(OH)D ile ilişkili bulundu (p=0.03). En sık görülen komorbidite hipertansiyon (%61,4) ve kalp yetmezliği idi (%27,1). Sigara içenlerde 25(OH)D düzeyi daha düşüktü (p=0,004). Son 12 aydaki alevlenme sıklığı ile serum 25(OH)D düzeyi düşüklüğü arasında ilişki saptandı (p=0.02). Sonuç: GOLD evrelemesine göre KOAH şiddeti ile 25(OH)D düzeyi düşüklüğü arasında ilişki vardır. Sigara içen KOAH hastalarında 25(OH)D düzeyi daha düşüktür. Ciddi Vitamin D eksikliği alevlenme sıklığında artış ile ilişkilidir. 25(OH)D düzeyi ile KOAH arasındaki ilişki, KOAH hastalarında Vitamin D düzeyini iyileştirmek gerektiğini düşündürmektedir.
Kronik obstruktif akciğer hastalığı ile vitamin D düzeyi arasındaki ilişki
Objective: Vitamin D deficiency may be associated with pulmonary function deterioration. The aim of this study is to assess the relationship of serum vitamin D levels with pulmonary functions, disease severity and exacerbation frequency in Chronic Obstructive Pulmonary Disease (COPD) patients. Methods: Seventy consecutive patients with COPD (Glob- al Initiative for Chronic Obstructive Lung Disease (GOLD) stage II-IV) who presented to our outpatient clinic and thirdty controls entered to the study. Diagnosis of COPD was confirmed according to clinical findings and pulmonary function test. Serum 25-hydroxyvitamin D (25(OH)D levels were measured by immunofluorescence method. Levels <20 ng/ mL defined deficiency. Associations between Vitamin D levels and sex, age, body mass index (BMI), smoking habit, comorbidities, exacerbation frequency were examined. Results: The mean age of patients was 60.7 years. The proportion of patients in stages 2 of GOLD was 40 %, in stages 3 was 30 % and stages 4was 30 %. There was no significant difference in serum levels of 25(OH)D between COPD patients and controls. Vitamin D level was 9.3 ±6.0 ng/mL in control group and 9.7± 8.5 ng/mL in GOLD stage 2, 9.6 ± 6.2 ng/mL in stage 3 and 5.1 ±2.4 ng/mL in stage 4. In stage 4, vitamin D levels was significantly lower statistically (p=0.03). Among the COPD patients, lower FEV1 was associated with lower levels of 25(OH)D (p= 0.03). The most frequent comorbidities were hypertension (61.4%) and heart failure (27.1%). Among the COPD patients smoking associated with significantly lower levels of serum 25(OH) D (p=0.04). We find an association with exacerbation frequency in the previous 12 months and levels of 25(OH) D (p=0.02). Conclusion: COPD severity according to GOLD stage is also associated with low levels of 25(OH)D. Serum vitamin D levels are lower in COPD patients who are current smokers. Severe vitamin D deficiency is related to more frequent disease exacerbations. These findings indicated a relationship between serum 25(OH)D concentrations and COPD which suggests optimization of serum vitamin D levels in COPD.
___
- 1. Holick MF.Vitamin D deficiency. N Engl J Med 2007; 357:266-281.
- 2. Cosio BG, Agusti A. Update in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 181:655- 660.
- 3. Penna G, Adorini L. 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000; 164: 2405-2411.
- 4. Lemire JM, Adams JS, Kermani-Arab V, et al. 1,25-Dihy- droxyvitamin D3 suppresses human T helper/inducer lym- phocyte activity in vitro. J Immunol 1985; 134:3032-3035.
- 5. Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008; 4:80-90.
- 6. Hansdottir S, Monick MM, Hinde SL, et al. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 2008; 181:7090-7099.
- 7. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2008; 57:847-852.
- 8. Schlaich C, Minne HW, Bruckner T, et al. Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos Int 1998; 8:261-267.
- 9. Dursun A. D vitamininin kemik metabolizması dışındaki etkileri. Beslenmede Yenilikler I-II, Katkı Pediatri Dergisi 2007; 28:225-234.
- 10. Timms PM, Mannan N, Hitman GA, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory dam- age in chronic disorders? QJM 2002; 95:787-796.
- 11. Banerjee A, Panettieri RJr. Vitamin D modulates airway smooth muscle function in COPD. Curr opin Pharmacol 2012
- 12. Wright RJ. Make no nounes about it: epidemiologic evidence links vitamin D to pulmonary function and COPD. Chest 2005;128: 3871-3873.
- 13. Sundar IK, Rahman I. Vitamin D and susceptibility of chronic lung disease: role of epigenetics. Front Pharmacol 2011; 2:50.
- 14. Erkkola M, Kaila M, Nwaru BI, et al. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis. Clin Exp Allergy 2009; 39:875-882.
- 15. Janssens W, Bouillon R, Claes B, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010; 65:215-220.
- 16. Janssens W, Mathieu C, Boonen S, Decramer M. Vitamin D deficiency and chronic obstructive pulmonary disease: a vicious circle. Vitam Horm 2011; 86:379-99.
- 17. Heulens N, Decramer M, Janssens W. Severe vitamin D deficiency: a biomarker of exacerbation risk? Am J Respir Crit Care Med. 2013; 187:214-215.
- 18. Holick MF.Vitamin D deficiency. N Engl J Med 2007; 357:266-281.
- 19. Murray CJ, Lopez AD. Alternative projections of mortality- and disability by cause 1990-2020: Global Burden of Disease Study.Lancet 1997; 349:1498-1504.
- 20. Strassels SA, Smith DH, Sullivan SD, Mahajan PS.The costs of treating COPD in the United States. Chest 2001;119:344-352.
- 21. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD, 2015 (update) www.goldcopd.com.
- 22. Norman AW, Bouillon R, Whiting SJ, et al. 13th Workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 2007; 103:204-205.
- 23. Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int 2005; 16:713- 716.
- 24. Alagöl F, Shihadeh Y, Boztepe H, et al. Sunlight exposure and vitamin D deficiency in Turkish Women. J Endocrinol Invest 2000; 23:173-177.
- 25. Pehlivan İ, Hatun Ş, Aydoğan M, et al. Maternal serum vitamin D levels in the third trimester of pregnancy. Turk J Med Sci 2002; 32:237-241.
- 26. Malabanan A, Veronikis IE, Holick MF.Redefining vitamin D insufficiency.Lancet 1998; 351:805-806.
- 27. Vitamin D: extraskeletal health.Holick MF. Rheum Dis Clin North Am. 2012 Feb; 38:141-160.
- 28. Kunisaki KM, Niewoehner DE, Singh RJ, Connett JE. Vitamin D status and longitudinal lung function decline in the Lung Health Study. Eur Respir J 2011; 37:238-243.
- 29. Black PN, Scragg R. Relationship between serum 25-hy- droxyvitamin D and pulmonary function in the third national health and nutrition examination survey.Chest 2005; 128:3792-3798.
- 30. Ringbaek T, Martinez G, Durakovic A, et al. Vitamin D status in patients with chronic obstructive pulmonary disease who participate in pulmonary rehabilitation. J Cardiopul- monary Rehab Prevention 2011; 31:261-267.
- 31. Franco CB, PazFillho G, Gomes PE, et al. Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int 2009;20:1881- 1887.
- 32. Persson LJP, Aanerud M, Hiemstra PS, et al. COPD is as- sociated with low levels of vitamin D. PLoS One 2012;7:6.
- 33. Celli BR, MacNee W. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932-946.
- 34. Semba RD, Chang SS, Sun K, et al.Serum 25-Hydroxyvi- tamin D and Pulmonary Function in Older Disabled Community-Dwelling Women. J Gerontol A Biol Sci Med Sci 2012; 67:683-689.
- 35. Shaheen SO, Jameson KA, Robinson SM, et al.Relationship of vitamin D status to adult lung function and COPD. Thorax 2011; 66:692-698.
- 36. Ampikaipakan SN, Hughes DA, Hughes JC, et al. Vitamin D and COPD: seasonal variation is important. Thorax 2011; 66:541-542.
- 37. Jenkins CR, Celli B, Anderson JA, et al. Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study.Eur Respir J. 2012; 39:38-45.
- 38. Lange NE, Sparrow D, Vokonas P, Litonjua AA.Vitamin D deficiency, Smoking, and Lung Function in the Normative Aging Study. Am J Respir Crit Care Med. 2012 Oct 1; 186:616-621.
- 39. Hughes DA, Norton R. Vitamin D and respiratory health. Clin Exp Immunol 2009; 158:20-25.
- 40. Lee JH, OKeefe JH, Bell D. Vitamin D deficiency an im- portant, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52:1949-1956.
- 41. Forman JP, Williams JS, Fisher ND.Plasma 25-hydroxyvitamin D and regulation of the renin angiotensin system in humans. Hypertension 2010; 55:1283-1288.
- 42. Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bio- availability of vitamin D in obesity. Am J Clin Nutr 2000; 72:690-693.
- 43. Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and Diabetes. Diabetologia 2005; 48:1247-1257.
- 44. McGill AT, Stewart JM, Lithander FE, et al. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 2008; 28:4-7.
- 45. Agusti A, Soriano JB.COPD as a systemic disease. COPD 2008; 5:133-138.
- 46. Marquis K, Debigare R, Lacasse Y, et al. Midthigh muscle crosssectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166:809- 813.
- 47. Cannell JJ, Vieth R, Umhau JC, et al. Epidemic influenza and vitamin D. Epidemiol Infect 2006;134: 1129-1140.
- 48. Wang TT, Nestel FP, Bourdeau V, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004; 173:2909- 2912.
- 49. Lehouck A, Mathieu C, Carremans C, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2012; 156:105-114.